Immunosuppressant FK506: Focusing on neuroprotective effects following brain and spinal cord injury

被引：25

作者：

Saganova, Kamila ^{[1
]}

Galik, Jan ^{[1
]}

Blasko, Juraj ^{[1
]}

Korimova, Andrea ^{[1
]}

Racekova, Eniko ^{[1
]}

Vanicky, Ivo ^{[1
]}

机构：

[1] Slovak Acad Sci, Inst Neurobiol, Ctr Excellence, Kosice 04001, Slovakia

来源：

LIFE SCIENCES | 2012年 / 91卷 / 3-4期

关键词：

Dosing regimen; Combined therapy; Functional outcome; Tissue sparing; FOCAL CEREBRAL-ISCHEMIA; THERAPEUTIC TIME WINDOW; TACROLIMUS FK506; FUNCTIONAL RECOVERY; CYCLOSPORINE-A; IMMUNE-RESPONSES; DAMAGE; RATS; METHYLPREDNISOLONE; FK-506;

D O I：

10.1016/j.lfs.2012.06.022

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The secondary damage that follows central nervous system (CNS) injury is a target for neuroprotective agents aimed at tissue and function sparing. FK506, a clinically used immunosuppressant, acts neuroprotectively in rat models of brain and spinal cord injury and ischemia. Evidence of in vivo experimental studies highlights the neuroprotective role of FK506 by its direct impact on various cell populations within the CNS. The participation of FK506 in modulation of post-traumatic inflammatory processes is a further potential aspect involved in CNS neuroprotection. In this review we provide an overview of the current laboratory research focusing on the multiple effects of FK506 on neuroprotection following CNS injury. (C) 2012 Elsevier Inc. All rights reserved.

引用

页码：77 / 82

页数：6

共 50 条

[31] FK506 Attenuates the Inflammation in Rat Spinal Cord Injury by Inhibiting the Activation of NF-κB in Microglia Cells
Gang Liu
Gentao Fan
Guodong Guo
Wenbo Kang
Dongsheng Wang
Bin Xu
Jianning Zhao
Cellular and Molecular Neurobiology, 2017, 37 : 843 - 855
[32] Effectiveness of minocycline and FK506 alone and in combination on enhanced behavioral and biochemical recovery from spinal cord injury in rats
Ahmad, Mohammad
Zakaria, Abdulrahim
Almutairi, Khalid M.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2016, 145 : 45 - 54
[33] Therapeutic Effects of FK506 on IgA Nephropathy Rat
Wei, Linting
Du, Yan
Jia, Lining
Ma, Xiaotao
Chen, Zhao
Lu, Jiamei
Tian, Lifang
Duan, Zhaoyang
Dong, Fengming
Lv, Zhian
Yao, Ganglian
Fu, Rongguo
Wang, Li
KIDNEY & BLOOD PRESSURE RESEARCH, 2017, 42 (06) : 983 - 998
[34] The immunosuppressant drug FK506 is a potent trophic agent for human fetal neurons
Avramut, M
Zeevi, A
Achim, CL
DEVELOPMENTAL BRAIN RESEARCH, 2001, 132 (02): : 151 - 157
[35] Immunosuppression with either cyclosporine A or FK506 supports survival of transplanted fibroblasts and promotes growth of host axons into the transplant after spinal cord injury
Hayashi, Y
Shumsky, JS
Connors, T
Otsuka, T
Fischer, I
Tessler, A
Murray, M
JOURNAL OF NEUROTRAUMA, 2005, 22 (11) : 1267 - 1281
[36] Immunosuppressant FK506 prevents mossy fiber sprouting induced by kindling stimulation
Moriwaki, A
Lu, YF
Hayashi, Y
Tomizawa, K
Tokuda, M
Itano, T
Hatase, O
Matsui, H
NEUROSCIENCE RESEARCH, 1996, 25 (02) : 191 - 194
[37] Neuroprotective effects of infliximab in experimental spinal cord injury
Kurt, Goekhan
Ergun, Ertan
Cemil, Berker
Borcek, Alp Ozgun
Borcek, Pelin
Gulbahar, Ozlem
Ceviker, Necdet
SURGICAL NEUROLOGY, 2009, 71 (03): : 332 - 336
[38] Neuroprotective Effects of Gabapentin in Experimental Spinal Cord Injury
Emmez, Hakan
Borcek, Alp Ozgun
Kaymaz, Memduh
Kaymaz, Figen
Durdag, Emre
Civi, Soner
Gulbahar, Ozlem
Aykol, Sukru
Pasaoglu, Aydin
WORLD NEUROSURGERY, 2010, 73 (06) : 729 - 734
[39] Pharmacokinetic animal PET study of FK506 as a potent neuroprotective agent
Murakami, Y
Takamatsu, H
Noda, A
Osoda, K
Ichise, R
Tatsumi, M
Tabata, K
Sawamoto, T
Nishimura, S
JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (11) : 1946 - 1949
[40] Effects of intrathecal administration of FK506 after sciatic nerve crush injury
Sarikcioglu, Levent
Duygulu, Erdeniz
Aydin, Hulya
Gurer, Elif Inanc
Ozkan, Olcay
Tuzuner, Serdar
JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 2006, 22 (08) : 649 - 654

← 1 2 3 4 5 →